Toba Hiroe | Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
スポンサーリンク
概要
- TOBA Hiroeの詳細を見る
- 同名の論文著者
- Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical Universityの論文著者
関連著者
-
Toba Hiroe
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Kobara Miyuki
Department Of Cardiology Kyoto First Red Cross Hospital
-
Kobara Miyuki
Department of Cardiology, Kyoto Prefectural University School of Medicine
-
Nakata Tetsuo
Department Of Cardiovascular Medicine Nantan General Hospital
-
Kobara Miyuki
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Nakata Tetsuo
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Nakata Tesuo
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Nakata Tetsuo
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
TOBA Hiroe
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Kobara Miyuki
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Nakamura T
Second Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Katamura Maki
Department Of Cardiology Kyoto Second Red Cross Hospital
-
Kobara Miyuki
Departments Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Katamura Maki
AMI-Kyoto Multi-Center Risk Study Group
-
Kimata Masaki
Department Of Cardiology Kyoto First Red Cross Hospital
-
Matsubara Hiroaki
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Matsubara Hiroaki
Department Of Cardiology Kyoto Prefectural University Of Medicine
-
Nomura Tetsuya
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Matsubara Hiroaki
Department Of Bioscience National Cardiovascular Center Research Institute
-
Hayashi Hironori
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Hayashi Hironori
Department Of Breast Oncology Aichi Cancer Center Hospital
-
TATSUMI Tetsuya
Department of Cardiovascular Medicine, Nantan General Hospital
-
Tatsumi Tetsuya
Department Of Cardiovascular Medicine Nantan General Hospital
-
Tatsumi Tetsuya
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Tatsumi Tetsuya
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Tatsumi Tetsuya
Department Of Cardiology Nantan General Hospital
-
Tatsumi T
First Department Of Medicine Nara Medical University
-
Nakamura Takeshi
Kyoto Prefectural University Of Medicine Department Of Cardiology
-
Tatsumi Tetsuya
Department of Cardiology and Vascular Regenerative Medicine, Kyoto Prefectural University School of Medicine
-
ABE Masaki
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Abe Masaki
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Yoshimura Akiko
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Inoue Riyako
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Sawai Naoki
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Morita Yosuke
Department Of Clinical Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical Universit
-
Yoshimura Akiko
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Matsumura Mihoko
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Sawai Naoki
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Inoue Riyako
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Abe Masaki
Department Of Agricultural Chemistry The University Of Tokyo
-
Matsumura Mihoko
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Tanaka Nana
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
TANAKA Takuya
Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University
-
Tatsumi T
Kyoto Prefectural University Of Medicine
-
Yoshida Mamiko
Department Of Clinical Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical Universit
-
Shimizu Takahiro
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Miki Shunsuke
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Tsukamoto Rie
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Morita Yosuke
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Miki Shunsuke
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Hamada Junichi
Department of Clinical Pharmacology, Division of Pathological science, Kyoto Pharmaceutical Universi
-
Furumori Akiko
Department of Clinical Pharmacology, Division of Pathological science, Kyoto Pharmaceutical Universi
-
Morishita Masayuki
Department of Clinical Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical Univers
-
Tsukamoto Rie
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Shimizu Takahiro
Department Of Cell Physiology National Institute For Physiological Sciences
-
Tanaka Takuya
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Hamada Junichi
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Furumori Akiko
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Morishita Masayuki
Department Of Clinical Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical Universit
-
Nakamura Takeshi
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Tanaka Takuya
Department Of Chemical Science And Engineering Graduate School Of Engineering Kobe University
-
Noda Kazuki
Department Of Cardiovascular Medicine Tohoku University Graduate School Of Medicine
-
Makino H
Department Of Medicine And Clinical Science Okayama University Graduate School Of Medicine And Denti
-
GOUDA Eri
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Gouda Eri
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Tanaka Kenta
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Tanaka Yoshimi
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Kitamura Miho
Department of Clinical Pharmacology, Division of Pathological science, Kyoto Pharmaceutical Universi
-
Noda Kazuki
Department of Clinical Pharmacology, Division of Pathological science, Kyoto Pharmaceutical Universi
-
Ohigashi Makoto
Department of Clinical Pharmacology, Division of Pathological science, Kyoto Pharmaceutical Universi
-
Uchida Yuugo
Department of Clinical Pharmacology, Division of Pathological science, Kyoto Pharmaceutical Universi
-
Mitani Takuya
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Nakae Takeshi
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Yukiya Ryosuke
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Yukiya Ryosuke
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Uchida Yuugo
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Matsuoka H
Kyoto Univ. Kyoto
-
Tanaka Kenta
Department Of Applied Chemistry School Of Engineering Osaka City University
-
Tanaka Yoshimi
Department Of Biology Faculty Of Science Kobe University
-
Noda Kazuki
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Tojo Chisato
Department Of Clinical Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical Universit
-
Kitamura Miho
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Mitani Takuya
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Ohigashi Makoto
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Tanaka Kenta
Department of Applied and Bioapplied Chemistry, Graduate School of Engineering, Osaka City University
-
YAMADA Hiroyuki
Department of Materials Engineering, Graduate school of Engineering, The University of Tokyo
-
Yamada Hiroyuki
Ami-kyoto Multi-center Risk Study Group
-
Tatsumi Tetsuya
Kyoto Prefectural University Of Medicine
-
Yokoi Hirokazu
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Tatsumi Tetsuya
京都第一赤十字病院 循環器科
-
Nakagawa Yoshitsugu
Department of Cardiology, Graduate School of Comprehensive Human Sciences, University of Tsukuba
-
Oshima Yuko
Department Of Biological Function And Genetic Resources Science Faculty Of Agriculture Okayama Unive
-
SHIRAISHI Tatsuya
Department of Orthopaedic Surgery, Kanazawa University
-
ASAYAMA Jun
National Hospital Organization Shiga Hospital
-
Tojo Chisato
Department of Clinical Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical Univers
-
Tsujimoto Shouta
Department of Clinical Pharmacology, Division of Pathological science, Kyoto Pharmaceutical Universi
-
Serizawa Ryoko
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Imai Nobuyoshi
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Morita Yusuke
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Nakashima Kohei
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Nakamori Ayako
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Narutaki Masako
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Hariu Hitoshi
Research and Development Laboratory, Shimaya Co., Ltd.
-
Tokitaka Masaaki
Research and Development Laboratory, Shimaya Co., Ltd.
-
Matsumura Mioko
Department of Clinical Pharmacology
-
Toba Hiroaki
Department of Clinical Pharmacology
-
Taira Masateru
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Murakami Masahumi
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Tamura Kazuya
Department of Clinical Pharmacology, Kyoto Phamaceutical University
-
Okamoto Akiharu
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Nakata Tesuo
Department of Clinical Pharmacology
-
Nakagawa Yoshitsugu
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Hariu Hitoshi
Research And Development Laboratory Shimaya Co. Ltd.
-
Nakamori Ayako
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Taira Masateru
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Narutaki Masako
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Tsutsumi Takeshi
First Department Of Medicine Nara Medical University
-
Tatsumi Tetsuya
First Department Of Internal Medicine Nara Medical University
-
Yamada Hiroyuki
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Tokitaka Masaaki
Research And Development Laboratory Shimaya Co. Ltd.
-
Tamura Kazuya
Department Of Clinical Pharmacology Kyoto Phamaceutical University
-
Serizawa Ryoko
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Nakashima Kohei
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Imai Nobuyoshi
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Matsubara Hiroaki
Division Of Cardiology And Nephrology Department Of Medicine Kyoto Prefectural University Of Medicin
-
Yokoyama Hitoshi
Division Of Nephrology Kanazwa Medical University
-
Tsujimoto Shouta
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Okamoto Akiharu
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Morita Yusuke
Department Of Applied Chemistry Graduate School Of Engineering Tohoku University
-
Miyoshi Hironori
Cardiovascular Division Department Of Medicine Ii Kansai Medical University
-
Shiraishi Tatsuya
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Hirata Yoshihide
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Yamada Hiroyuki
Department Of Anatomy School Of Dentistry Aichi-gakuin University
-
NAKANO Arisa
Department of Clinical Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University
-
KOJIMA Yushi
Department of Clinical Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University
-
WANG Jiahong
Department of Clinical Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University
-
KOBARA Miyuki
Department of Clinical Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University
著作論文
- Aldosterone Nongenomically Produces NADPH Oxidase-Dependent Reactive Oxygen Species and Induces Myocyte Apoptosis
- PJ-477 PPARs Ligands Exhibit the Direct Anti-atherosclerotic Effect by Inhibiting ACE Expression in Streptozotocin-induced Diabetic Rat Aorta(Atherosclerosis, basic-5 (H) PJ80,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the
- Channel Blockers Reduce Angiotensin II-Induced Superoxide Generation and Inhibit Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Expression in Endothelial Cells
- Calcium Channel Blockades Exhibit Anti-Inflammatory and Antioxidative Effects by Augmentation of Endothelial Nitric Oxide Synthase and the Inhibition of Angiotensin Converting Enzyme in the N^G-Nitro-L-Arginine Methyl Ester-Induced Hypertensive Rat Aorta
- PJ-164 Additive Suppression of Mitochondria- and NADPH Oxidase-derived ROS by Combined Aldosterone and Angiotensin Receptor Blockers in Post-infarct Failing Hearts(PJ028,Cardiovascular Pharmacology (Basic), Cost-health care system/DPC/Laws (H),Poster Sess
- DPJ-064 Chronic Administration of Recombinant Human Erythropoietin Exhibits Anti-inflammatory and Anti-oxidative Effects in Experimental Diabetic Rat Aorta beyond Hematopoiesis(DPJ11,Cardiovascular Pharmacology (Basic) (H),Digital Poster Session (Japanese
- FRS-072 Imatinib Induces Autophagy-Mediated Cell Death in Cardiac Myocytes(FRS15,Novel Molecular Mechanisms of Heart Failure 1 (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-346 Pitavastatin Exhibited Direct Renoprotective Effects and Inhibited CYP11B2 and ACE Expression in the Uninephrectomized Streptozotocin-induced Diabetic Rat Kidney(Kidney/Renal circulation(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Me
- PJ-112 Aldosterone Activates Apoptosis Signal-Regulating Kinase 1 (ASK-1) through Nongenomical ROS production and Induces Myocyte Apoptosis.(Heart failure, basic(05)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulatio
- PJ-053 Short-Term Caloric Restriction Improves Mitochondrial Oxidative Stress and Myocyte Apoptosis in Cardiac Pressure-Overload Hypertrophy(Cardiac hypertrophy, basic/clinical(02)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japa
- OJ-109 Chronic Administration of Recombinant Human Erythropoietin Ameliorates Renal Injury in Experimental Diabetic Rats beyond Hematopoiesis(Kidney/Renal circulation(02)(H),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Ci
- PJ-819 Erythropoietin Exhibits Renoprotective Effects in the Streptozotocin-Induced Diabetic Rats(Kidney/Renal circulation-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-764 Aldosterone Directly Induces Myocyte Apoptosis through NADPH Oxidase-Derived Reactive Oxygen Species(Development and differentiation-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-638 Histidine Exerts Anti-Hypertensive Effect via Central H3 Receptor and Increases the NOx Content in RVLM(Hypertension, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-430 Spironolactone Suppresses Production of Mitochondrial Reactive Oxygen Species and Improves Cardiac Function in Post-infarct Failing Hearts(Heart failure, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-157 Spironolactone Reduced Renal Injury and Inhibited Hyperglycemia-Induced Overexpression of CYP11B2 in Uninephrectomized Streptozotocin-Induced Diabetic Rats(Kidney / Renal circulation-2, The 71st Annual Scientific Meeting of the Japanese Circulation
- PJ-401 Aldosterone Rapidly Activates MEK-ERK1/2 Signaling Pathway via Membrane Bound Mineralocorticoid Receptor(Heart failure, basic-5 (M) PJ68,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-322 Anti-Interleukin-6 Antibody Attenuates Left Ventricular Remodeling after Myocardial Infarction in Mice(Acute myocardial infarction, basic-2 (IHD) OJ54,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circu
- Ca Channel Blockades Show Anti-inflammatory and Anti-oxidative Effects by the Inhibition of ACE in L-NAME induced hypertensive Rat Aorta (Hypertension, Basic 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats